| Index | — | P/E | 10.82 | EPS (ttm) | 0.76 | Insider Own | 0.22% | Shs Outstand | 1.51B | Perf Week | 0.86% |
| Market Cap | 12.42B | Forward P/E | 7.25 | EPS next Y | 1.13 | Insider Trans | 0.00% | Shs Float | 1.48B | Perf Month | -2.72% |
| Enterprise Value | 12.79B | PEG | 51.52 | EPS next Q | — | Short Float | 0.19% | Perf Quarter | -12.37% | ||
| Income | 1.18B | P/S | 0.41 | EPS this Y | 31.48% | Short Ratio | 0.54 | Perf Half Y | 2.24% | ||
| Sales | 30.38B | P/B | 1.21 | EPS next Y | -0.56% | ROA | 0.30% | Short Interest | 2.75M | Perf YTD | 6.61% |
| Book/sh | 6.78 | P/C | 3.10 | EPS next 5Y | 0.21% | ROE | 12.23% | 52W High | 9.61 -14.10% | Perf Year | 8.44% |
| Cash/sh | 2.65 | P/FCF | 37.09 | EPS past 3/5Y | — | ROIC | 0.28% | 52W Low | 6.75 22.30% | Perf 3Y | 73.42% |
| Dividend Est. | 0.49 (5.90%) | EV/EBITDA | 9.80 | Sales past 3/5Y | — -8.15% | Gross Margin | 82.52% | Volatility | 0.95% 1.05% | Perf 5Y | 57.47% |
| Dividend TTM | 0.49 (5.88%) | EV/Sales | 0.42 | EPS Y/Y TTM | -0.50% | Oper. Margin | 3.71% | ATR (14) | 0.13 | Perf 10Y | 93.87% |
| Dividend Ex-Date | Sep 03, 2026 | Quick Ratio | — | Sales Y/Y TTM | 21.97% | Profit Margin | 3.85% | RSI (14) | 41.06 | Recom | 2.94 |
| Dividend Gr. 3/5Y | 28.90% 44.10% | Current Ratio | — | EPS Q/Q | 34.45% | SMA20 | -0.55% | Beta | 0.89 | Target Price | 7.50 |
| Payout | 62.92% | Debt/Eq | 0.43 | Sales Q/Q | 9.64% | SMA50 | -5.49% | Rel Volume | 0.97 | Prev Close | 8.22 |
| Employees | 15,304 | LT Debt/Eq | 0.43 | Earnings | Feb 18 | SMA200 | -1.02% | Avg Volume | 5.38M | Price | 8.26 |
| IPO Date | Jun 28, 1985 | Option/Short | Yes / Yes | EPS/Sales Surpr. | — | Net Debt/EBITDA | 0.28 | Volume | 5,198,104 | Change | 0.43% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| May-15-26 | Downgrade | Morgan Stanley | Overweight → Equal Weight | |
| Dec-03-25 | Downgrade | UBS | Buy → Neutral | |
| May-07-25 | Upgrade | Exane BNP Paribas | Neutral → Outperform | |
| May-28-24 | Downgrade | UBS | Buy → Neutral | |
| May-16-24 | Reiterated | CFRA | $7.50 | |
| Dec-02-21 | Upgrade | UBS | Sell → Neutral | |
| Dec-01-21 | Upgrade | UBS | Sell → Neutral | |
| Nov-24-21 | Upgrade | Credit Suisse | Neutral → Outperform | |
| Nov-23-21 | Upgrade | Credit Suisse | Neutral → Outperform | |
| Apr-20-21 | Upgrade | Societe Generale | Sell → Hold |
Aegon Ltd. functions as a leading financial services provider, offering a comprehensive suite of insurance, retirement planning, and asset management solutions across its operational regions in the Americas, the Netherlands, and the United Kingdom. The company's diverse product range includes life, accident, and health insurance, alongside property and casualty coverage. It also facilitates wealth growth and retirement security through savings vehicles, pensions, annuities, mutual funds, individual retirement accounts, voluntary employee benefits, and stable value programs. Beyond these, Aegon deals in various financial instruments such as debt and mortgage-backed securities, derivatives, reinsurance assets, and short-term investments, while also delivering services like credit risk management, disability assistance, and innovative digital banking platforms. Established in 1983 as Aegon N.V., the firm's main offices are located in The Hague, Netherlands.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 30,384 | 30,306 | 21,118 | 14,038 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 5,411 | 23,911 | 0 | 19,131 | — | — | — | — | — | |
| Gross Profit | 24,973 | 6,395 | 21,118 | 2,561 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 547 | 2,221 | 2,145 | 2,041 | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Other Operating Expense | 23,276 | -709 | 18,262 | 942 | — | — | — | — | — | |
| Operating Income | 1,137 | 1,132 | 711 | 13,384 | — | — | — | — | — | |
| Interest Expense | 351 | 365 | 6 | 8 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 351 | 412 | 10 | -13,800 | — | — | — | — | — | |
| Net Income Before Taxes | 1,137 | 1,179 | 714 | -423 | — | — | — | — | — | |
| Income Taxes | 46 | 70 | -17 | -226 | — | — | — | — | — | |
| Consolidated Net Income | 1,181 | 1,102 | 744 | -194 | — | — | — | — | — | |
| Net Income From Continuing Operations | 1,091 | 1,106 | 731 | -197 | — | — | — | — | — | |
| Net Income | 1,181 | 1,102 | 744 | -194 | — | — | — | — | — | |
| EPS (Recurring) | 0.76 | 0.68 | 0.40 | -0.13 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 0.76 | 0.68 | 0.40 | -0.13 | — | — | — | — | — | |
| EPS (Diluted) | 0.76 | 0.68 | 0.32 | -0.13 | — | — | — | — | — | |
| EBITDA | 1,305 | 1,317 | 687 | -221 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 10.86 | 11.39 | 18.15 | — | — | — | — | — | — | |
| Price To Sales Ratio | 0.43 | 0.40 | 0.56 | 0.78 | — | — | — | — | — | |
| Gross Margin | 82.19 | 21.10 | 100.00 | 18.24 | — | — | — | — | — | |
| Operating Margin | 3.74 | 3.74 | 3.37 | 95.34 | — | — | — | — | — | |
| Net Margin | 3.89 | 3.64 | 3.52 | -1.38 | — | — | — | — | — | |
| Shares Outstanding | 1,573 | 1,562 | 2,010 | 1,891 | — | — | — | — | — | |
| Market Capitalization | 12,985 | 12,043 | 11,839 | 10,892 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |